Jiang et al. [24] conducted a study demonstrating that the transrectal biopsy approach yielded higher prostate cancer detection rates than the transperineal technique in patients with PSA levels ranging from 0.1 to 100 ng/mL (80.8% vs. 69.1%, respectively; p = 0.04). This evidence concerns the gene KLK3 and prostate carcinoma.